Post-operative analgesia and spinal block duration following total hip arthroplasties - comparison of single-shot intrathecal ropivacaine, and bupivacaine: a randomized, double blinded controlled study

Status

Not yet recruiting

Phases

Phase 4

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2025-522358-38-02

Enrollment

158

Registered

2025-10-31

Start date

Unknown

Completion date

Unknown

Last updated

2025-10-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hip osteoarthrosis and postoperative pain

Brief summary

Return of sensory and motor function, Same day discharge rate, Length of stay in the postoperative care unit and length of hospital stay

Detailed description

Post-operative pain evaluated using the Numeric Rating Scale (NRS), Urinary retention, Post-operative nausea and vomiting, Postoperative opioid consumption in morphine milligram equivalents (MME), Patient satisfaction will be evaluated using a 5-point Likert scale, Perioperative hemodynamics, Onset time of block, Adequacy of anesthesia

Interventions

DRUGBicain Spinal 5 mg/ml injektioneste

DRUGliuos

DRUGRopivacain Fresenius Kabi 5 mg/ml injektioneste

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Design outcomes

Primary

Measure	Time frame
Return of sensory and motor function, Same day discharge rate, Length of stay in the postoperative care unit and length of hospital stay	—

Secondary

Measure	Time frame
Post-operative pain evaluated using the Numeric Rating Scale (NRS), Urinary retention, Post-operative nausea and vomiting, Postoperative opioid consumption in morphine milligram equivalents (MME), Patient satisfaction will be evaluated using a 5-point Likert scale, Perioperative hemodynamics, Onset time of block, Adequacy of anesthesia	—

Countries

Finland

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026